HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indre Januskeviciene Selected Research

tetraphenylphosphonium (tetraphenylphosphonium chloride)

1/2021Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Indre Januskeviciene Research Topics

Disease

1Breast Neoplasms (Breast Cancer)
01/2021
1Neoplasms (Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

1tetraphenylphosphonium (tetraphenylphosphonium chloride)IBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2021